Nov. 1, 2026 — GE HealthCare recently introduced Allia Celeo,* a ceiling-mounted image guiding system, at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. Developed ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
-
-
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce significant weight loss, according to a laboratory study led by Cedars-Sinai ...
-
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a series of new rules from the Centers for Medicare & Medicaid Services (CMS). Earlier ...
-
Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to effective heart failure care by predicting the expected effects of treatment on ...
Oct. 29, 2026 — Abbott has initiated the CROWN-MV pivotal trial evaluating the safety and effectiveness of its ...
November 05, 2026
Nov. 1, 2026 — GE HealthCare recently introduced Allia Celeo,* a ceiling-mounted image guiding system, at the ...
November 05, 2026
Nov. 2, 2026 — At the Transcatheter Cardiovascular Therapeutics (TCT) annual conference in San Diego, Calif. Medtronic ...
November 04, 2026
Oct. 29, 2026 — Instylla, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved the expanded ...
November 03, 2026
Oct. 29, 2026 — Johnson & Johnson has announced 26 presentations featuring the clinical science of Impella heart pumps ...
October 30, 2026
Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...
October 30, 2026
Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...
October 23, 2026
Oct. 22, 2026 — Henry Ford Health has performed the first procedures globally in a clinical trial evaluating pulmonary ...
October 23, 2026
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...
October 19, 2026
Oct. 14, 2026 — W. L. Gore & Associates' medical business has announced U.S. Food and Drug Administration approval of an ...
October 14, 2026
Medical device portfolios now move on two very different clocks. New technologies can gain clinical adoption within ...
October 14, 2026
Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...
October 13, 2026
Oct. 6, 2026 — Penumbra, Inc. has announced results from a subset analysis of the landmark STORM-PE randomized ...
October 09, 2026
Oct. 5, 2026 — Abbott has announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF ...
October 05, 2026
Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The new identity ...
October 05, 2026